4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0000950170-25-027070
Options or other derivatives
- Chief Financial Officer acquired 28,362 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pizzie Nick Chief Financial Officer | 2025-02-21 | Grant or award · Employee Stock Option (Right to Buy) | +9,516 | 9,516 | D: show line 1 in the form | ||
| Pizzie Nick Chief Financial Officer | 2025-02-21 | Grant or award · Restricted Stock Units | +9,423 | 9,423 | D: show line 2 in the form | ||
| Pizzie Nick Chief Financial Officer | 2025-02-24 | Grant or award · Performance Stock Units | +9,423 | 9,423 | D: show line 3 in the form |
Loading xslF345X05/ownership.xml…